美国食品和药物管理局批准的慢性GVHD治疗方法
Stephanie J Lee1,2, Robert Zeiser3
1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Blood
|January 9, 2025
概括
慢性移植与宿主疾病 (cGVHD) 是干细胞移植后的一个困难并发症. 最近FDA批准的药物向特定的途径和细胞,改善cGVHD患者的治疗选择.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 慢性移植与宿主疾病 (cGVHD) 是全源造血细胞移植后的一个重大并发症.
- cGVHD会影响多个器官,降低生活质量,并由于不良影响而带来治疗挑战.
研究的目的:
- 审查美国食品和药物管理局 (FDA) 最近批准的cGVHD治疗方法.
- 讨论这些新型治疗方法的向信号通路和细胞类型.
- 概述cGVHD临床研究的未来研究方向.
主要方法:
- 对支持FDA批准新cGVHD药物的临床研究的审查.
- 对ibrutinib, ruxolitinib, belumosudil 和 axatilimab 的向作用机制的分析.
- 关于cGVHD当前和未来临床研究的讨论.
主要成果:
- 在过去的十年中,FDA批准了四种药物 (ibrutinib, ruxolitinib, belumosudil, axatilimab) 用于治疗cGVHD.
- 这些疗法针对特定的分子通路和涉及cGVHD病变的细胞相互作用.
- 临床试验是这些批准的基础,证明了疗效和安全性.
结论:
- 最近的治疗进展为管理cGVHD提供了新的选择.
- 了解向途径和细胞类型对于优化治疗策略至关重要.
- 继续进行临床研究对于进一步改善cGVHD患者的治疗结果至关重要.
相关概念视频
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
01:22Bone Marrow Sampling and Transplants
279
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
279
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:40Cell-mediated Immune Responses
66.8K
Overview
66.8K